Genetic dissection of type 2 diabetes

Molecular and Cellular Endocrinology

Volumn 297, Issue 1-2, 2009, Pages 10-17

  Ridderstråle, Martin ^a   Groop, Leif ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Association study; Complex disease; Epigenetic; Genetics; Genome wide scan; Linkage study; Monogenic; Obesity; Polygenic; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

CALPAIN 10; DNA METHYLTRANSFERASE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; METFORMIN; NEUROGENIC DIFFERENTIATION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SULFONYLUREA; TRANSCRIPTION FACTOR 7 LIKE 2;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA METHYLATION; EPIGENETICS; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHARMACOGENETICS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WSF 1 GENE;

AGING; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OBESITY; PHENOTYPE;

EID: 57649210496     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.10.002     Document Type: Review

References (82)

1. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., Lane C.R., Schaffner S.F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T.J., Daly M., Groop L., and Lander E.S. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 (2000) 76-80
2. Bouchard C., Perusse L., Leblanc C., Tremblay A., and Theriault G. Inheritance of the amount and distribution of human body fat. Int J Obesity 12 (1988) 205-215
3. Brosseau J., Eelkema R., Crawford A., and Abe T. Diabetes among the three affiliated tribes: correlations with degree of Indian inheritance. Am J Public Health 69 (1979) 1277-1278
4. Carey D., Nguyen T., Campbell L., Chisholm D., and Kelly P. Genetic influences on central abdominal fat: a twin study. Int J Obesity 20 (1996) 722-726
5. Carlsson E., Poulsen P., Storgaard H., Almgren P., Ling C., Björn Jensen C., Madsbad S., Groop L., Vaag A., and Ridderstråle M. Genetic and non-genetic regulation of CAPN10 mRNA expression skeletal muscle. Diabetes 54 (2005) 3015-3020
6. Consindine R., Consindine E., William C., Nyce M., Magosin S., Bauer T., Rosato E., Colberg J., and Caro J. Evidence against either a premature stop codon or the abscence of obese gene mRNA in human obesity. J Clin Invest 95 (1995) 2986-2988
7. Cox N.J., Frigge M., Nicloale D.L., Concannon P., Hanis C.L., Spielman R.S., Berll G.I., and Kong A. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 2 (1999) 213-215
8. Deeb S.S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., Laakso M., Fujimoto W., and Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20 (1998) 284-287
9. Diabetes Genetics Inititative. Genome wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
10. Dina C., Meyre D., Gallina S., et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39 (2007) 724-726
11. Florez J.C., Burtt N., de Bakker P.I.W., Almgren P., Tuomi T., Holmkvist J., Gaudet D., Hudson T.J., Schaffner S.S., Daly M.J., Hirschhorn J.N., Groop L., and Altshuler D. Haplotype structure and genotype-phenotype correlations of the sulfonyulrea receptor (SUR1) and the islet ATP- sensitive potassium channel (kir 6.2) gene region. Diabetes 53 (2004) 1360-1368
12. Frayling T., Timpson N.J., Weedon M.N., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 (2007) 889-894
13. Frayling T.M., Colhoun H., and Florez J.C. A genetic link between type 2 diabetes and prostate cancer. Diabetologia 51 (2008) 1757-1760
14. Gerken T., Girard C.A., Tung Y.-C.L., et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318 (2008) 146-148
15. Gloyn A.L., Weedon M.N., Owen K.R., et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunit Kir 6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCJN11 W23K variant is associated with type 2 diabetes. Diabetes 52 (2003) 568-572
16. Gloyn A.L., Pearson E.R., Antcliff J.F., et al. Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350 (2004) 1838-1849
17. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38 (2006) 320-323
18. Grarup N., Rose C.S., Andersson E.A., et al. Studies of association of variants near the HHEX, CDKN2A/2B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10 705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 56 (2007) 3105-3111
19. Grarup N., Andersen G., Krarup N.T., et al. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes 57 (2008) 2534-2540
20. Groop L., Forsblom C., Lehtovirta M., Tuomi T., Karanko S., Nissén M., Ehrnström B.-O., Forsén B., Isomaa B., Snickars B., and Taskinen M.-R. Metabolic consequences of a family history of NIDDM (The Botnia Study)-evidence for sex-specific parental effects. Diabetes 45 (1996) 1585-1593
21. Gudmundsson J., Sulem P., Steinthorsdottir V., et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39 (2007) 977-983
22. Hales C., and Barker D. Type 2 diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35 (1992) 595-601
23. Hanis C.L., Boerwinkle E., Chakraborty R., Ellsworth D.L., Concannon P., Stirling B., Morrison V.A., Wapelhorst B., Spielman R.S., Gogolin-Ewens K.J., Shepard J.M., Williams S.R., Risch N., Hinds D., Iwasaki N., Ogata M., Omori Y., Petzold C., Rietzch H., Schroder H.E., Schulze J., Cox N.J., Menzel S., Boriraj V.V., Chen X., et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13 (1996) 161-166
24. Helgadottir A., Thorleifsson G., Manolesco A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (2007) 1491-1493
25. Herbert A., Gerry N.P., McQueen M.B., Heid I.M., Peufer A., Illig T., et al. A common genetic variant is associated with adult and childhood obesity. Science 312 (2006) 279-283
26. Holmkvist J., Cervin C., Lyssenko V., Winkler W., Anevski D., Cilio C., Almgren P., Berglund G., Nilsson P., Lindgren C.M., Altshuler D., and Groop L. Common variants in the MODY3 gene (HNF-1α) and risk of type 2 diabetes. Diabetologia 49 (2006) 2882-2891
27. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T.H., Mashima H., Schwarz P.E., del Bosque-Plata L., Horikawa Y., Oda Y., Yoshiuchi I., Colilla S., Polonsky K.S., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L.J., Bogardus C., Groop L., Boerwinkle E., Hanis C.L., and Bell G.I. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26 (2000) 163-175
28. Hotamisligil G., Shargill N., and Spiegelman B. Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
29. Israeli Research Group. Normal fasting plasma glucose levels and type 2 diabetes in young men. New Engl J Med 353 (2005) 1454-1462
30. Jackson R., Creemers J., Ohagi S., Raffin-Sanson M.-L., Sanders L., Montague C., Hutton J., and O'Rahilly S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 16 (1997) 303-306
31. Jacobsson J.A., Klovins J., Kapa I., et al. Novel genetic variant in FTO influences insulin levels and insulin resistance in severely obese children and adolescents. Int J Obes (2008) [Epub ahead of print]
32. Kaprio J., Tuomilehto J., Koskenvuo M., Romanov K., Reunanen A., Eriksson J., Stengard J., and Kesaniemi Y.A. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35 (1992) 1060-1067
33. Köbberling J., and Tillil H. Empirical risk figures for first-degree relatives of no-insulin dependent diabetics. In: Köbberling J., and Tattersall R. (Eds). The Genetics of Diabetes Mellitus (1982), Academic Press, London 201-209
34. Krude H., Biebermann H., Luck W., Horn R., Brabant G., and Grueters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19 (1998) 155-157
35. Laaksonen D.E., Lakka H.M., Niskanen L.K., Kaplan G.A., Salonen J.T., and Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort. Am J Epidemiol 156 (2002) 1070-1077
36. Larsen L.H., Echwald S.M., Sorenssen T.I., Andersen T., Wulff B.S., and Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 90 (2005) 219-224
37. Li C., Scott L.J., and Boehnke M. Assessing whether an allele can account in part for a linkage signal: the Genotype-IBD Sharing Test (GIST). Am J Hum Genet 74 (2004) 418-431
38. Ling C., Poulsen P., Carlsson E., Ridderstråle M., Almgren P., Beck-Nielsen H., Groop L., and Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins. J Clin Invest 114 (2004) 1518-1526
39. Loos R.J., Lindgren C.M., Li S., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 40 (2008) 768-775
40. Lorenzo C., Okolosie M., Williams K., Stern M.P., and Haffner S.M. The metabolic syndrome as a predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26 (2003) 3153-3159
41. Luan J., Browne P.O., Harding A.H., Halsall D.J., O'Rahilly S., Chatterjee V.K., and Wareham N.J. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50 (2001) 686-689
42. Lyon H.N., Emilsson V., Hinney A., Heid I.M., Lasky-Su J., Zhu X., et al. The association of a SBP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PloS Genet 3 (2007) e61
43. Lyssenko V., Almgren P., Anevski D., Perfekt R., Lahti K., Isomaa B., Forsen B., Nissén M., Homström N., Saloranta C., Taskinen M.-R., Groop L., and Tuomi. Predictors and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54 (2005) 166-174
44. Lyssenko V., Anevski D., Almgren P., Sjogren M., Svensson M., Orho-Melander M., Tuomi T., and Groop L. Genetic prediction of type 2 diabetes. PloS Med 2 (2005) 1299-1308
45. Lyssenko V., Orho-Melander M., Sjögren M., Ling C., Lupi R., Marchetti P., DelPrato S., Eriksson K.-F., Lethagen A.-L., Berglund G., Tuomi T., Nilsson P., and Groop L. Common variants in the TCF7L2 gene increase risk of future type 2 diabetes by influencing pancreatic alpha and beta-cell function. J Clin Invest 117 (2007) 2155-2163
46. Maffei M., Halaas J., Ravussin E., Pratley R., Lee G., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P., and Friedman J. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1 (1995) 1155-1161
47. McPherson R., Pertsemilidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 (2007) 14888-14891
48. Melander O., Mattiasson I., Marsal K., Groop L., and Hulthen L. Heredity for hypertension influences intrauterine growth and the relation between foetal growth and adult blood pressure. J Hypertension 17 (1999) 1557-1561
49. Memisoglu A., Hu F.B., Hankinson S.E., Manson J.A.E., De Vivo I., Willett W.C., and Hunter D.J. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 12 (2003) 2923-2929
50. Montague C., Farroqi S., Whitehead J., Soos M., Rau H., Wareham N., Sewter C., Digby J., Mohammed S., Hurst J., Cheetham C., Earley A., Barnett A., Prins J., and O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 (1997) 903-908
51. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., and Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34 (2003) 267-273
52. Neel V. Diabetes mellitus: a "thrifty"genotype rendered detrimental by progress?. Am J Hum Genet 14 (1962) 352-362
53. Newman B., Selby J.V., King M.C., Slemenda C., Fabsitz R., and Friedman G.D. Concordance for type 2 diabetes in male twins. Diabetologia 30 (1987) 763-768
54. Nichols C.G., and Koster J.C. Diabetes and insulin secretion: whiter KATP?. Am J Physiol Endocrinol Metab 283 (2002) E403-E412
55. Parikh H., and Groop L. Candidate genes for type 2 diabetes. Rev Endocr Metab Disord 5 (2004) 151-176
56. Pascoe L., Tura A., Patel S.K., et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 56 (2007) 3101-3104
57. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., and Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci 100 (2003) 8466-8471
58. Pearson E.R., Starkey B.J., Powell R.J., et al. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362 (2003) 1275-1281
59. Pearson E.R., FlecthnerI, Njolstad P.R., et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355 (2006) 467-477
60. Pearson E.R., Donnelly L.A., Kimber C., et al. Variations in TCF7L2 influences therapeutic response to sulfonylureas. A GoDARTs Study. Diabetes 56 (2007) 2178-2182
61. Pelleymounter M., Cullen M., Baker M., Hecht R., Winters D., Boone T., and Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 (1995) 540-542
62. Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., Argyropoulos G., Walts B., Pérusse L., and Bouchard C. The human obesity gene map: the 2005 update. Obeisty 14 (2006) 529-644
63. Samaras K., Spector T., Nguyen T., Baan K., Campbell L., and Kelly P. Independent genetic factors determine the amount and distribution of fat in women after the menopause. J Clin Endocrinol Metab 82 (1997) 781-785
64. Sandhu M.S., Weedon M.N., Fawcett K.A., et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 39 (2007) 951-953
65. Scott L., Moehlke K., Bonnycatle L.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007) 1341-1345
66. Serjeantson S., Owerbach D., Zimmet P., Nerup J., and Thoma K. Genetics of diabetes in Nauru. Effects of foreign admixture. HLA antigens and insulin-gene linked polymorphism. Diabetologia 25 (1983) 13-17
67. Sladek R., Rochelau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
68. Staiger H., Machicao F., Stefan N., et al. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS ONE 2 (2007) e832
69. Staiger H., Stancakova A., Zilinskaite J., et al. A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study. Diabetes 57 (2008) 514-517
70. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39 (2007) 770-775
71. Thomas G., Jacobs K.B., Yeager M., et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40 (2008) 310-315
72. Unoki H., Takahashi A., Kawaguchi T., et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 40 (2008) 1098-1102
73. Vaisse C., Clement K., Guy-Grand B., and Froguel P. A frameshift mutation in human MCR4 is associated with a dominant form of obesity. Nat Genet 20 (1998) 113-114
74. Weedon M.N., McCarthy M.I., Hitman G., et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 3 (2006) e374
75. Winckler W., Weedon M.J., Graham R.R., McCarroll S.A., Purcell S., Almgren P., Tuomi T., Gaudet D., Bengtsson Boström K., Walker M., Hitman G., Hattersley A.T., McCarthy M.I., ArdlieKG, Hirschhorn J.N., Daly M.J., Frayling T.M., Groop L., and Altshuler D. Evaluation of common variants in six known MODY genes for association with type 2 diabetes. Diabetes 56 (2007) 685-693
76. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
77. Yasuda K., Miyake K., Horikawa Y., et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 40 (2008) 1092-1097
78. Yeo G., Farooqi I., Aminian S., Halsell D., Stanhope R., and O'Rahilly S. A frameshift mutation in MCR4R associated with dominantly inherited human obesity. Nat Genet 20 (1998) 111-112
79. Ylönen K, Salminen I, Lyssenko V, Virtanen SM, Groop L, Aro A, Saloranta C, 2007. The Pro12Ala polymorphism of the PPAR-γ2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. Eur J Clin Nutr, in press.
80. Zeggini E., Weedon M.N., Lindgren C.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1440
81. Zeggini E., Scott L.J., Saxena R., et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40 (2008) 638-645
82. Zhang Y., Proenca R., Maffei M., Baron M., Leopold L., and Friedman J. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432